Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 15th, 2019 |
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) |
National Institutes of Health |
| December 21st, 2021 |
Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) |
National Institutes of Health |
| October 28th, 2021 |
Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) |
National Institutes of Health |
| January 10th, 2022 |
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 10th, 2022 |
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 22nd, 2019 |
The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
| December 2nd, 2019 |
Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required) |
National Institutes of Health |
| December 2nd, 2019 |
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (U24 - Clinical Trial Required -Infrastructure) |
National Institutes of Health |
| March 17th, 2020 |
Scaling Capacity in Strategic and Health Information Systems in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
| March 10th, 2020 |
Accelerating and Sustaining HIV Epidemic Control and Related Diseases in Western and West-Nile Regions in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
| March 11th, 2022 |
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 16th, 2022 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) |
National Institutes of Health |
| February 19th, 2020 |
Achieving and Maintaining Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Haut Katanga Region of the Democratic Republic of Congo under the President's Emergency Plan for |
Centers for Disease Control CGH |
| April 24th, 2020 |
Improving Quality of Care and Health Impact through Innovative Systems and Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
| March 9th, 2020 |
Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 30th, 2019 |
USAID/Uganda Voluntary Family Planning for Improved Reproductive Health and Development (FP4HD) Activity |
Uganda USAID Kampala |
| November 26th, 2019 |
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2022 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2022 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2022 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
National Institutes of Health |
|
| September 7th, 2022 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
National Institutes of Health |
| November 12th, 2019 |
National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC) |
Centers for Disease Control NCHHSTP |
| May 27th, 2022 |
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 20th, 2022 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 27th, 2022 |
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 11th, 2019 |
Health Workforce Improvement Program (HWIP) |
Ethiopia USAID Addis Ababa |
| October 7th, 2019 |
Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER) |
Malawi USAID Lilongwe |
| September 3rd, 2019 |
Combating Opioid Overdose through Community Level Intervention |
Office of National Drug Control Policy |
| September 24th, 2019 |
Health Services Delivery (HSD) Activity |
Senegal USAID Dakar |
| February 24th, 2020 |
Evaluating Practice-based Programs, Policies, and Practices from CDCs Rape Prevention and Education (RPE) Program: Expanding the Evidence to Prevent Sexual Violence |
Centers for Disease Control and Prevention ERA |
| December 15th, 2019 |
ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure |
Centers for Disease Control ATSDR |
| March 9th, 2020 |
Strengthening Civil Society Organizations' Capacity and Coordination for Accelerated HIV Epidemic Control in Uganda through Supporting Implementation of Comprehensive HIV/AIDS Prevention and Treatment for Key |
Centers for Disease Control CGH |
| March 9th, 2020 |
Strengthening the Government of Uganda's Capacity for Regionally Centered and District Implemented HIV and TB Programming through Health Information Systems, Case Based Surveillance, Monitoring, Evaluation and Quality |
Centers for Disease Control CGH |
| February 19th, 2020 |
Strategic Use of Surveillance and Epidemiology to Support HIV Epidemic Control in Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
| March 10th, 2020 |
Enhancing Strategic Information Capacity for HIV/AIDS Programs towards Sustaining Epidemic Control in Kenya through Monitoring and Evaluation and Data Science under the President's Emergency Plan for AIDS Relief |
Centers for Disease Control CGH |
| March 11th, 2020 |
Achieving Undetectable=Untransmittable in India through Quality Laboratory Testing, Workforce Development, Improved Result Utilization, and Strong Laboratory Epidemiology Platforms for Informed Public Health Response |
Centers for Disease Control CGH |
| January 28th, 2020 |
Implementation of Sustainable Laboratory Quality Systems for HIV/TB Epidemic Control in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
| January 17th, 2020 |
Achieving and Maintaining Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Kinshasa Region of the Democratic Republic of Congo under the President's Emergency Plan for AIDS |
Centers for Disease Control CGH |
| September 7th, 2020 |
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2020 |
National Asian Language Tobacco Use and Dependence Treatment Support System |
Centers for Disease Control NCCDPHP |
